Wasatch Advisors LP Raises Stake in Viemed Healthcare, Inc. (NASDAQ:VMD)

Wasatch Advisors LP lifted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 19.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,848,884 shares of the company's stock after buying an additional 303,277 shares during the period. Wasatch Advisors LP owned about 4.75% of Viemed Healthcare worth $13,552,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company's stock worth $16,803,000 after purchasing an additional 617,009 shares during the last quarter. Price T Rowe Associates Inc. MD bought a new stake in shares of Viemed Healthcare in the 1st quarter valued at about $97,000. Summit Global Investments boosted its holdings in Viemed Healthcare by 109.5% during the 2nd quarter. Summit Global Investments now owns 33,973 shares of the company's stock valued at $223,000 after acquiring an additional 17,760 shares during the period. Penbrook Management LLC grew its position in Viemed Healthcare by 236.0% during the 2nd quarter. Penbrook Management LLC now owns 231,607 shares of the company's stock worth $1,517,000 after acquiring an additional 162,670 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Viemed Healthcare by 11.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 95,388 shares of the company's stock worth $625,000 after purchasing an additional 9,792 shares during the period. Institutional investors own 74.24% of the company's stock.

Insider Transactions at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now directly owns 107,706 shares of the company's stock, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nitin Kaushal sold 5,995 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $8.58, for a total value of $51,437.10. Following the completion of the transaction, the director now directly owns 126,843 shares of the company's stock, valued at $1,088,312.94. This represents a 4.51 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 72,256 shares of company stock worth $674,739. 20.00% of the stock is currently owned by insiders.

Viemed Healthcare Trading Up 1.3 %

Shares of NASDAQ:VMD traded up $0.11 during trading on Friday, reaching $8.67. 64,502 shares of the company traded hands, compared to its average volume of 223,887. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 52-week low of $6.21 and a 52-week high of $10.44. The firm has a market capitalization of $337.61 million, a price-to-earnings ratio of 32.11 and a beta of 1.43. The business's fifty day moving average is $8.61 and its 200-day moving average is $7.62.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The company had revenue of $58.00 million during the quarter.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.